2025-03-25
Propharma and Suzhou Chung-Hwa Chemical & Pharmaceutical explore new opportunities for cooperative development—strong alliance, innovation and win-win!

On the afternoon of March 24, 2025, a team led by General Manager Li of the API Business Department of Propharma Co., Ltd. (hereinafter referred to as "Propharma") visited Suzhou Chung-Hwa Chemical & Pharmaceutical Industrial Co., Ltd. (hereinafter referred to as "Suzhou Chung-Hwa Chemical & Pharmaceutical"), and the two sides had in-depth exchanges on deepening strategic cooperation in the pharmaceutical field.



Corporate Style

On the day of the event, Suzhou Chung-Hwa Product Manager Sheng Guanxing gave a detailed introduction to the visiting leaders of Propharma on the company's historical heritage, corporate culture, core products, technological innovation, etc. He also visited the pharmaceutical R&D center and production line and provided product quality assurance.



Win-win cooperation

During the talks, Propharma and Suzhou Chung-Hwa Chemical & Pharmaceutical discussed the direction of cooperation, combining Propharma's advantages in large-scale production of raw materials with Suzhou Chung-Hwa Chemical & Pharmaceutical's experience in formulation technology and clinical research to jointly promote a new model of innovative cooperation.



Propharma

Founded in 1989, Propharma Co., Ltd. is a pharmaceutical industry platform under Hengdian Group, one of the top 100 most valuable listed companies on the Chinese main board, and one of the second batch of "Eagle Action" cultivation enterprises in Zhejiang Province. It mainly engages in API, CDMO, and preparation business, and its products involve cardiovascular, anti-infection, psychiatric, anti-tumor and other treatment fields. The production bases are located in Dongyang, Zhejiang, Weifang, Shandong, Dongzhi, Anhui, and Quzhou, Zhejiang.


Continuous innovation

Suzhou Chung-Hwa Chemical & Pharmaceutical continues to deepen its efforts, innovate and make breakthroughs in the pharmaceutical field, and is committed to providing the people with safer and more effective medicines and services. At the same time, the company sticks to its original aspirations, continues to pay attention to the needs of the people and society, actively participates in public welfare undertakings, demonstrates its responsibility and commitment with practical actions, and contributes to the prosperity and progress of society.


Share